For research use only
| Cat No. | ABC-SC0134T |
| Product Type | Canine Primary Cells |
| Cell Type | Monocyte |
| Species | Canine |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Bone Marrow |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Canine BMMCs from healthy Beagles aid hematopoiesis, immune response, and drug safety studies with diverse cells,suspended growth, and stable properties.
Canine Bone Marrow Mononuclear Cells (cBM-MNCs) are isolated from the bone marrow of healthy dogs and represent a heterogeneous population comprising hematopoietic stem cells, mesenchymal stromal cells, lymphocytes, and monocytes. These cells display round-to-oval morphology with varying nucleus-to-cytoplasm ratios and are adherent or non-adherent based on subpopulation characteristics. Canine MNCs serve as an important immunological and regenerative model, particularly relevant for studying hematological disorders, immune modulation, and transplantation biology. They express markers such as CD34, CD45, and MHC-II, with subsets displaying multilineage differentiation potential. cBM-MNCs are widely used in canine models of autoimmune diseases, osteoarthritis, and graft-versus-host disease (GVHD), facilitating translational studies due to similarities with human bone marrow physiology. These canine bone marrow-derived mononuclear cells provide a relevant model for comparative immunology and regenerative research.
| Product Code | Canine Bone Marrow Mononuclear Cells, cBM-MNC, Canine Bone Marrow Mononuclear Cells |
| Species | Canine |
| Cat.No | ABC-SC0134T |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Monocyte |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Bone Marrow |
| Disease | Normal |
| Storage | Liquid Nitrogen |
| Product Type | Canine Primary Cells |
Canine Bone Marrow Mononuclear Cells are extensively used in preclinical studies related to stem cell therapy, immune modulation, and hematopoietic regeneration. They support investigations into bone marrow transplantation, gene therapy, and autoimmune conditions such as immune-mediated hemolytic anemia. Their multipotent capacity makes them valuable in musculoskeletal regeneration, wound healing, and cardiology research, providing a translational bridge between veterinary and human medicine.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).